Zyceva 150 mg Tablet
  1. Home
  2. Pharma Products
  3. Cadila Healthcare Ltd
  4. Zyceva 150 mg Tablet

Zyceva 150 mg Tablet

Zyceva 150 mg Tablet contains erlotinib, a targeted anticancer medicine used mainly for non-small cell lung cancer and pancreatic cancer. It is an oral tablet taken according to the prescribed treatment plan. Erlotinib blocks EGFR signaling, which helps slow the growth and spread of certain cancer cells.

BUY NOW

Category

Zyceva 150 mg Tablet belongs to the tyrosine kinase inhibitor class and works by inhibiting epidermal growth factor receptor activity involved in cancer-cell growth. It is commonly used for specific types of advanced or metastatic non-small cell lung cancer and in combination therapy for advanced pancreatic cancer. The tablet is generally taken once daily on an empty stomach, at least 1 hour before or 2 hours after food, as directed by the physician. Regular medical monitoring may be required to assess treatment response and possible adverse effects.

Technical Specification

Specification Details
Active Ingredient Erlotinib
Strength 150 mg
Dosage Form Tablet
Route of Administration Oral
Pack Size 30 Tablets
Manufacturer/Marketer Zydus Lifesciences Ltd

Product Also Known As

Zyceva 150 mg Tablet, Zyceva 150 Tablet, Zyceva Erlotinib Tablet, Erlotinib 150 mg Tablet, Erlotinib Cancer Tablet, Erlotinib Lung Cancer Tablet